An observational study in Systolic Heart Failure, sponsored by Medtronic BRC. Status unknown at 5 sites in 3 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-09-23.
Sponsored by Medtronic BRC · Observational
The purpose of this study is to determine whether heart rate variability-like parameters are related to changes in the disease status of a subject that suffers from a disease that decreases the pumping function of the heart.
5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.
This study's planned enrollment of 60 is below the median of 200 across 1,679 observational studies indexed under Heart Failure.
Browse Heart Failure studies →Medtronic BRC is the lead sponsor of 25 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Systolic Heart Failure Patients with NYHA class II or III and a ventricular ejection fraction of less then 40%.
Exclusion Criteria:
HF diagnostic
Time frame: 2 years
This study is status unknown, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medtronic BRC